SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
JAMA Neurology - United States
doi 10.1001/jamaneurol.2013.593
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2013
Authors
Publisher
American Medical Association (AMA)